Tharimmune (NASDAQ:THAR) stock is falling on Tuesday after the clinical-stage biotechnology company announced a public offering for its shares. That public offering has Tharimmune selling 10 million shares of THAR stock. These shares are being sold for $1 each. Underwriters also have a 45-day…
#thar #tharimmune #thinkequity #th104 #esglholdings #esgl #riskoninternational #williamwhite
Continue reading...